Assessment of gold nanoparticles as a size-dependent vaccine carrier for enhancing the antibody response against synthetic foot-and-mouth disease virus peptide
- PMID: 20400818
- DOI: 10.1088/0957-4484/21/19/195101
Assessment of gold nanoparticles as a size-dependent vaccine carrier for enhancing the antibody response against synthetic foot-and-mouth disease virus peptide
Abstract
To assess the ability of gold nanoparticles (GNPs) to act as a size-dependent carrier, a synthetic peptide resembling foot-and-mouth disease virus (FMDV) protein was conjugated to GNPs ranging from 2 to 50 nm in diameter (2, 5, 8, 12, 17, 37, and 50 nm). An extra cysteine was added to the C-terminus of the FMDV peptide (pFMDV) to ensure maximal conjugation to the GNPs, which have a high affinity for sulfhydryl groups. The resultant pFMDV-GNP conjugates were then injected into BALB/c mice. Immunization with pFMDV-keyhole limpet hemocyanin (pFMDV-KLH) conjugate was also performed as a control. Blood was obtained from the mice after 4, 6, 8, and 10 weeks and antibody titers against both pFMDV and the carriers were measured. For the pFMDV-GNP immunization, specific antibodies against the synthetic peptide were detected in the sera of mice injected with 2, 5, 8, 12, and 17 nm pFMDV-GNP conjugates. Maximal antibody binding was noted for GNPs of diameter 8-17 nm. The pFMDV-GNPs induced a three-fold increase in the antibody response compared to the response to pFMDV-KLH. However, sera from either immunized mouse group did not exhibit an antibody response to GNPs, while the sera from pFMDV-KLH-immunized mice presented high levels of binding activity against KLH. Additionally, the uptake of pFMDV-GNP in the spleen was examined by inductively coupled plasma mass spectroscopy (ICP-MS) and transmission electron microscopy (TEM). The quantity of GNPs that accumulated in the spleen correlated to the magnitude of the immune response induced by pFMDV-GNP. In conclusion, we demonstrated the size-dependent immunogenic properties of pFMDV-GNP conjugates. Furthermore, we established that GNPs ranging from 8 to 17 nm in diameter may be ideal for eliciting a focused antibody response against a synthetic pFMDV peptide.
Similar articles
-
Gold nanoparticles regulate the blimp1/pax5 pathway and enhance antibody secretion in B-cells.Nanotechnology. 2014 Mar 28;25(12):125103. doi: 10.1088/0957-4484/25/12/125103. Epub 2014 Feb 27. Nanotechnology. 2014. PMID: 24576992
-
Synthetic peptides against foot-and-mouth disease--immunization with VP1-peptides of type O1-Kaufbeuren.Arch Exp Veterinarmed. 1990;44(6):883-90. Arch Exp Veterinarmed. 1990. PMID: 1966360
-
Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.Vaccine. 2008 Mar 10;26(11):1471-81. doi: 10.1016/j.vaccine.2007.12.053. Epub 2008 Jan 24. Vaccine. 2008. PMID: 18289743
-
Cell activation and immunogenicity.Dev Biol Stand. 1986;63:29-39. Dev Biol Stand. 1986. PMID: 3527819 Review.
-
Production of antipeptide antisera.Curr Protoc Neurosci. 2001 May;Chapter 5:Unit 5.6. doi: 10.1002/0471142301.ns0506s00. Curr Protoc Neurosci. 2001. PMID: 18428505 Review.
Cited by
-
Metal-based nanoparticle in cancer treatment: lessons learned and challenges.Front Bioeng Biotechnol. 2024 Jul 11;12:1436297. doi: 10.3389/fbioe.2024.1436297. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 39055339 Free PMC article. Review.
-
PEGylated Gold Nanoparticles Target Age-Associated B Cells In Vivo.ACS Nano. 2022 Nov 22;16(11):18119-18132. doi: 10.1021/acsnano.2c04871. Epub 2022 Oct 27. ACS Nano. 2022. PMID: 36301574 Free PMC article.
-
Metal-Based Compounds in Antiviral Therapy.Biomolecules. 2022 Jul 3;12(7):933. doi: 10.3390/biom12070933. Biomolecules. 2022. PMID: 35883489 Free PMC article. Review.
-
Utilization of metal or non-metal-based functional materials as efficient composites in cancer therapies.RSC Adv. 2022 Feb 24;12(11):6540-6551. doi: 10.1039/d1ra08335j. eCollection 2022 Feb 22. RSC Adv. 2022. PMID: 35424648 Free PMC article. Review.
-
Conjugation of Y. pestis F1-antigen to gold nanoparticles improves immunogenicity.Vaccine. 2012 Nov 6;30(48):6777-82. doi: 10.1016/j.vaccine.2012.09.021. Epub 2012 Sep 18. Vaccine. 2012. PMID: 23000121 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources